http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-205903-U1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-10
filingDate 2021-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-205903-U1
titleOfInvention DEVICE FOR STOPPING POSTAL UTERINE BLEEDING
abstract The utility model relates to medicine, in particular to obstetrics, and is used to stop postpartum pathological uterine bleeding. The device for stopping postpartum uterine bleeding contains two elastic balloons made with the possibility of placement in the uterine cavity and located in series on one base of the elastic catheter having an opening at the distal end of its axial canal. The device contains, at the proximal end, two Luer-Lock connectors for connecting containers with liquid for independent filling of the distal and proximal balloons, the channels of which are located inside the main axial canal, and the distal balloon is made larger than the proximal balloon, and between the balloons on the axial an additional opening is located in the channel of the catheter. The technical result of the utility model is the ability to stop bleeding by separately or simultaneously filling the distal and / or proximal parts of the balloon with liquid, depending on the location of the bleeding zone. 1 wp f-ly, 7 ill.
priorityDate 2021-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9888927-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2410047-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2708328-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7708716-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID57926
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID38288
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25504
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5020
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18429
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID57926
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439302
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507320
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280888
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100152272
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID352920
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4813803

Total number of triples: 30.